|D013119||Spinal Cord Injuries NIH||0.58|
|D001930||Brain Injuries, NIH||0.45|
|D014947||Wounds and Injuries NIH||0.18|
There is one clinical trial.
Study Objectives: To perform COVID-19 diagnostic and serologic testing on emergency medical personnel in Polk County to determine: 1. COVID-19 prevalence 2. Rate of convalesced personnel (+antibodies) 3. Rate of asymptomatic carriers
Description: To assess the prevalence of COVID-19 amongst county emergency personnelMeasure: Prevalence of COVID-19 amongst county emergency personnel Time: May-December 2020
Description: To correlate common COVID-19 symptoms with result of COVID-19 testMeasure: Correlation of common COVID-19 symptoms with result of COVID-19 test Time: May-December 2020
Description: Co-existence of influenza and COVID-19 positive test results with or without symptomsMeasure: Co-existence of influenza and COVID-19 positive test results Time: May-December 2020
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports